Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egyptarticle Published on 2023-02-042024-09-05 Journal: Virology Journal [Category] update2024, [키워드] Allogeneic autologous hematopoietic stem cell transplantation HHV-6 reactivation HSCT human herpesvirus 6 [DOI] 10.1186/s12985-023-01980-w PMC 바로가기 [Article Type] article
Evaluation of humoral immune responses induced by different SARS-CoV-2 spike trimers from wild-type and emerging variants with individual, sequential, and combinational delivered strategiesArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome Antibody Response antibody response against autologous binding circulating coronavirus coronavirus disease COVID-19 Delta effective heterogenous homologous humoral immune response immunization immunogenicity indicated induce monovalent vaccine multivalent vaccine neutralizing antibody Neutralizing antibody response omicron produced regimen SARS-CoV-2 SARS-CoV-2 spike trimer significantly spike Spike protein spike trimer strain supported trimer Vaccination strategies Vaccination strategy Vaccine Vaccines variant variants viruses wild type wild-type [DOI] 10.1002/jmv.28081 PMC 바로가기
Humanized mice for investigating SARS-CoV-2 lung infection and associated human immune responsesArticle Published on 2022-10-012022-11-15 Journal: European Journal of Immunology [Category] COVID19(2023년), SARS, 치료기술, [키워드] acute respiratory syndrome animal model anti-SARS-CoV-2 Anti-viral immune response associated immune response autologous chemotaxis coronavirus coronavirus disease Defense detectable Differentially expressed genes hemorrhage HISL mice human immune response Human immune system human lung humanized humanized mouse IFN Immune cell infiltration Immunopathogenesis immunopathology in viral in vivo model infected with SARS-CoV-2 infecting lack Live virus Lung infection mice multiple organ NSG mice pulmonary fibrosis responses SARS-CoV-2 SARS-COV-2 infection Support susceptible therapeutic Therapies tissue Vero Cell [DOI] 10.1002/eji.202249804 PMC 바로가기
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral SclerosisRandomized Controlled Trial Published on 2022-08-292022-10-05 Journal: Neurology® neuroimmunology & neuroinflammation [Category] 바이오마커, 임상, [키워드] 1:1 ALS assigned autologous average baseline changed class classification clinical study Combined conducted COVID-19 pandemic Disease progression Dose escalation dose-escalation doses effective elevated enrolled Evidence extension Good group help IL-2 Inflammation injection intervals Lateral Sclerosis LDL Leukapheresis low-density marker matching placebo Open-label oxidative stress oxidized participant Patient Person Placebo Practice progression provide Randomized controlled trial Randomly RCT receive receptor Regulatory reliability Safe slow disease suppressive function T-lymphocyte therapy Treatment Treg Tregs Year [DOI] 10.1212/NXI.0000000000200019 PMC 바로가기 [Article Type] Randomized Controlled Trial
The role of autologous micrografts injection from the scalp tissue in the treatment of COVID-19 associated telogen effluvium: Clinical and trichoscopic evaluationClinical Trial Published on 2022-07-012022-10-05 Journal: Dermatologic therapy [Category] COVID19(2023년), SARS, 임상, [키워드] acute respiratory syndrome asymptomatic infection autologous autologous micrografts caused characterized clinical Coronavirus-2 COVID-19 COVID-19 infection epithelial evaluate evaluated Follow-up generate hair follicle hair follicles infected with SARS-CoV-2 injection life-threatening management manifestation multiorgan disease Patient SARS-CoV-2 stem cell stem cells structures suffered telogen effluvium therapeutic tissue Treatment [DOI] 10.1111/dth.15545 PMC 바로가기 [Article Type] Clinical Trial
Breast reconstruction during the COVID-19 pandemic: Single institution experience from the pandemic’s epicenter in the United StatesCOVID-19 대유행 중 유방 재건: 미국의 대유행 진원지에서 단일 기관 경험Article Published on 2022-07-012022-09-11 Journal: Medicina [Category] COVID19(2023년), SARS, 변종, [키워드] analyzed autologous Breast Breast cancer Breast reconstruction Cancer screening Care changed changes in conducted coronavirus disease Coronavirus disease-19 COVID-19 COVID-19 pandemic declined Delta determine effort increase in lowest mammography New York City omicron pandemic performed reconstruction reduced retrospective Screening subsequent summer surgical surgical treatment Surveillance the United State track Treatment variants Volume while [DOI] 10.1016/j.bjps.2022.02.021 PMC 바로가기 [Article Type] Article
Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency공통 가변성 면역 결핍증에서 2개의 ChAdOx1 nCoV-19 후 BNT162b2 부스팅에 의해 유도된 특정 항체 및 T-세포 반응Article Published on 2022-06-172022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 immunoglobulin Anti-spike antibody autologous BNT162b2 BNT162b2 vaccine booster vaccination CD19 CD19+ CD3+ CD3+CD4+ CD3+CD8+ CD4+ CD45 CD45+ CD8+ Cell cell count cell counts cell-mediated response ChAdOx1 ChAdOx1 nCoV-19 changes in common common variable immunodeficiency common variable immunodeficiency (CVID) Control Coronavirus-2 COVID-19 infection cumulative cut-off value CVID decrease ELISPOT ELISpot assay evaluated except for flow cytometric healthy control healthy controls healthy individual healthy individuals humoral IFN-γ IFN-γ ELISPOT IFN-γ ELISpot assay IFN-γ producing T cells immune response immunodeficiency Immunoglobulin Immunoglobulin G immunosuppressive immunosuppressive therapy individual interferon interferon-γ Killer cell less Lymphocytes measure morbidity natural killer natural killer cell not different not significant Patient patients positive Primary Immunodeficiency producing protein S raised receiving response Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 shown Side effects significant difference significant differences significantly significantly lower Specific statistically stem cell Stem cell transplantation T cell T cell response T cells tested therapy These data vaccination Vaccinations variable virus-specific T cell virus-specific T-cell with COVID-19 [DOI] 10.3389/fimmu.2022.907125 PMC 바로가기 [Article Type] Article
Adaptation of the PERCEPT myeloma prehabilitation trial to virtual delivery: changes in response to the COVID-19 pandemic가상 분만에 대한 PERCEPT 골수종 사전 재활 시험의 적응: COVID-19 전염병에 대한 대응의 변화Review Published on 2022-04-082022-09-11 Journal: BMJ Open [Category] 임상, [키워드] adaptation addition autologous benefit bone Bone marrow Bone marrow transplantation change changes in clinical pathway COVID-19 COVID-19 pandemic development effective enrolled Exercise intervention feasibility highlight impacted Intervention Myeloma pandemic participant Participants pathway patients physical activity provided Randomised trial recipients recruit recruitment registration number rehabilitation rehabilitation medicine required Research Ethics Research Ethics Committee stem cell Stem cell transplantation Study protocol Trial trial protocol [DOI] 10.1136/bmjopen-2021-059516 PMC 바로가기 [Article Type] Review
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial Research Published on 2022-03-212022-10-05 Journal: Nature Medicine [Category] 바이오마커, 임상, [키워드] 95% CI 95% confidence interval Anti-CD19 autologous B-cell B-cell lymphoma Blood level CAR Central nervous system chimeric antigen receptor CNS Complete CRS Cytokine release syndrome Cytokines effective EFS evaluated event events Follow-up median median time multicenter neurologic nine occurred outcome Patient primary endpoint Primary outcome reached remained safety profile secondary single-arm survival T-cell therapy Treatment Trial [DOI] 10.1038/s41591-022-01731-4 [Article Type] Research
mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in micemRNA로 인코딩된 HIV-1 Env 삼량체 페리틴 나노입자는 생쥐에서 이종 HIV-1 분리물을 중화시키는 단클론 항체를 유도합니다Article Published on 2022-03-152022-09-12 Journal: Cell Reports [Category] MERS, 진단, [키워드] acquisition antigenic autologous B cell broadly neutralizing antibodies complex COVID-19 vaccine Critical demonstrated expression ferritin Heterologous HIV-1 immunogen induce isolate knock-in mice lineages Lipid nanoparticle Lipid nanoparticles mice monoclonal antibody mRNA mRNA-LNP mutations neutralize Neutralizing Neutralizing activity neutralizing antibody nucleoside-modified mRNA precursor priming Protein Sequencing serum trimer Vaccine Vaccine development [DOI] 10.1016/j.celrep.2022.110514 PMC 바로가기 [Article Type] Article